Covid-19 roundup: CDC de­bat­ing who should get first avail­able vac­cines; EU in Gilead talks af­ter US gob­bled first remde­sivir dos­es

The fed­er­al gov­ern­ment has now spent bil­lions of dol­lars ac­cel­er­at­ing the de­vel­op­ment of a Covid-19 vac­cine, and yet they’ve re­mained hush-hush on who, pre­cise­ly, would …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER